Zhen ci yan jiu = Acupuncture research · 2013
[Effects of electroacupuncture intervention on blood lipid levels and expression of CD 40 L and MMP-9 in the coronary artery tissue in coronary heart disease rats].
Аннотация на английскомСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Meng, Cai Rong-Lin, Sun Xu, Hu Ling, Wang Ke-Ming, He Lu, Peng Chuan-Yu
Аннотация
OBJECTIVE: To observe the effect of electroacupuncture (EA) of "Neiguan" (PC 6) and "Xinshu" (BL 15) on levels of serum total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL) and low-density lipoprotein (LDL) and expression of T cell CD 40 L and matrix metalloproteinases-9 (MMP-9) in the coronary artery in coronary heart disease (CHD) rats, so as to reveal its mechanism underlying improvement of coronary atherosclerotic heart disease.
METHODS: A total of 60 Wistar rats were randomly divided into normal control, model, EA-pretreatment, routine EA and medication groups (n = 12). Coronary atherosclerotic heart disease model was established by feeding the animals with high fat forage for 3 months and intraperitoneal injection of VD3 (2 mL/kg, 60 000 IU/100 g, once daily for 3 days). EA was applied to unilateral "Neiguan"(PC 6) and "Xinshu"(BL 15) once every other day for rats of the EA-pretreatment group from the 1st day of modeling on for 12 weeks, and once daily for rats of the routine EA group from successful modeling on for 2 weeks. Rats of the medication group were treated by intragastric administration of Atorvastatin 0. 25 mg . kg-1 . d-1 for 2 weeks. Serum TC, TG, HDL and LDL contents were detected by ELISA and the expression levels of CD 40 L and MMP-9 of the coronary artery tissue assayed by Western blot.
RESULTS: Serum contents of TC, TG and LDL and expression levels of coronary arterial CD 40 L and MMP-9 in the model group were significantly higher than those of the normal control group( P<0.01), while serum HDL content was decreased considerably in the mo- del group (P<0. 01). In comparison with the model group, the contents of serum TC, TG, HDL and the expression levels of arterial CD 40 L and MMP-9 in both EA-pretreatment group and routine EA group were remarkably down-regulated (P<0. 01), and serum LDL content was obviously up-regulated (P<0. 01). The effects of the EA-pretreatment group were significantly superior to those of the medication group in down-regulating the contents of serum TC, TG, HDL and decreasing the expression of coronary arterial CD 40 L and MMP-9 proteins (P<0. 01, P<0. 05). No significant differences were found between the EA-pretreatment and routine EA groups in all the 6 indexes (P>0. 05).
CONCLUSION: Both EA-pretreatment and routine EA of PC 6 and BL 15 can down-regulate blood TC, TG and HDL contents, raise serum HDL level and suppress the increased expression of CD 40 L and MMP-9 proteins of coronary artery tissue in rats with coronary atherosclerotic heart disease, which may contribute to their effect in improving CHD.
METHODS: A total of 60 Wistar rats were randomly divided into normal control, model, EA-pretreatment, routine EA and medication groups (n = 12). Coronary atherosclerotic heart disease model was established by feeding the animals with high fat forage for 3 months and intraperitoneal injection of VD3 (2 mL/kg, 60 000 IU/100 g, once daily for 3 days). EA was applied to unilateral "Neiguan"(PC 6) and "Xinshu"(BL 15) once every other day for rats of the EA-pretreatment group from the 1st day of modeling on for 12 weeks, and once daily for rats of the routine EA group from successful modeling on for 2 weeks. Rats of the medication group were treated by intragastric administration of Atorvastatin 0. 25 mg . kg-1 . d-1 for 2 weeks. Serum TC, TG, HDL and LDL contents were detected by ELISA and the expression levels of CD 40 L and MMP-9 of the coronary artery tissue assayed by Western blot.
RESULTS: Serum contents of TC, TG and LDL and expression levels of coronary arterial CD 40 L and MMP-9 in the model group were significantly higher than those of the normal control group( P<0.01), while serum HDL content was decreased considerably in the mo- del group (P<0. 01). In comparison with the model group, the contents of serum TC, TG, HDL and the expression levels of arterial CD 40 L and MMP-9 in both EA-pretreatment group and routine EA group were remarkably down-regulated (P<0. 01), and serum LDL content was obviously up-regulated (P<0. 01). The effects of the EA-pretreatment group were significantly superior to those of the medication group in down-regulating the contents of serum TC, TG, HDL and decreasing the expression of coronary arterial CD 40 L and MMP-9 proteins (P<0. 01, P<0. 05). No significant differences were found between the EA-pretreatment and routine EA groups in all the 6 indexes (P>0. 05).
CONCLUSION: Both EA-pretreatment and routine EA of PC 6 and BL 15 can down-regulate blood TC, TG and HDL contents, raise serum HDL level and suppress the increased expression of CD 40 L and MMP-9 proteins of coronary artery tissue in rats with coronary atherosclerotic heart disease, which may contribute to their effect in improving CHD.